News
Managing a robust and resilient supply of medicines
Source: DHSC/Gov.uk 11.8.25 The UK is not alone in facing challenges with medicines shortages, with many other nations experiencing disruption. In the UK, there is no single, reliable measure that...
Backdated pay uplift causes headaches for Practice Managers
Source: Practice Index 7.8.25 NHS England has confirmed a rise in the global sum for GP practices in England, increasing payments from £121.79 to £123.34 per weighted patient. This...
Class 4 Medicines Defect Notification: Topiramate Zydus Pharmaceuticals UK 20mg/ml Oral Solution, Zydus Pharmaceuticals UK Ltd, EL(25)A/39
Source: MHRA/Gov.uk 07.08.2025 Zydus Pharmaceuticals UK LTD has informed the MHRA that there is an error on the artwork for the outer carton and Patient Information Leaflet (PIL) of Topiramate...
Keeping Your Dispensary Informed:
Brand Comparisons, Profitability Insights & Top Tips from Dispex Are you staying ahead of the changes? At Dispex, we continually monitor changes within the dispensing world, updating our brand comparison...
Strips Update- No good for dispensing practices
Source: NHS England 2.6.25 Commissioning recommendations following the second national assessment of blood glucose and ketone meters, testing strips and lancets. Click here to read in full. This does not...
Active Serious shortage protocols (SSPs)
Source:NHSBSA/ SSP Active SSPs Name of SSP \ ref no. Start and end date Supporting guidance SSP082 Estradot® 25 microgram patches (PDF:218KB) 03 April 2025 to 10 October 2025 This SSP...
The House of Lords: inquiry into the UK’s ability to predict and prevent medicine supply issues
Source: UK Parliament The House of Lords Public Services Select Committee has launched an inquiry into the UK’s ability to predict and prevent medicine supply issues. This is a public...
Safeguards to prevent diversion of medicines from registered pharmacies
While this article highlights recent concerns within pharmacies, several of the recommended safeguards are also applicable to dispensaries. Source: General Pharmaceutical Council 6.8.25 The GPhC has recently investigated some...
Class 2 Medicines Recall: Fucidin 250 mg Tablets, LEO Laboratories Ltd trading as LEO Pharma, EL(25)A/38
Source: MHRA/Gov.uk 04.08.2025 LEO Pharma is recalling the affected batch as a precautionary measure due to out of specification results for impurities during routine stability testing. DMRC reference number DMRC-36306427...
Health Exemption Services Communications Toolkits
Source: NHSBSA The NHS Business Services Authority has published a series of toolkit and promotional materials to help healthcare professionals, local authorities and public health teams promote the NHS Health...
Class 4 Medicines Defect Notification: Olmesartan medoxomil 10mg film-coated tablets, Jubilant Pharmaceuticals NV, EL(25)A/37
Source: MHRA/Gov.uk 31.7.25 Jubilant Pharmaceuticals NV has informed the MHRA that the Patient Information leaflet (PIL) in the cartons for the batches listed in this notification include an outdated PIL....
Stay Informed with the Dispex WhatsApp Support Group!
The group offers a supportive space where you can share best practices, ask questions and exchange knowledge with fellow professionals. Remember, there’s no such thing as a silly question-we’re all here to learn...
